Friedl-Naderer Johanna 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Friedl-Naderer Johanna（CIK 1915598）在 1 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-09-08）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 900 | $21,915 |
| 2026-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 185 | $3,493 |
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 226 | $5,939 |
| 2026-06-17 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 145 | $2,658 |
| 2026-05-14 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 228 | $4,186 |
| 2026-03-06 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 148 | $2,205 |
| 2026-02-17 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 买入 | 60,000 | $0 |
| 2025-12-05 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 144 | $2,984 |
| 2025-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 894 | $11,863 |
| 2025-09-08 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 144 | $1,931 |
| 2025-06-06 | Dyne Therapeutics, Inc. (DYN) | Chief Commercial Officer | 卖出 | 146 | $1,949 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08